HF50

· HighField Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HF50, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors [EARLY_Phase 1]